| Summer Knight, RN, CNM | |
|
1411 E 31st St, Oakland, CA 94602-1018 | |
| (510) 435-8845 | |
| Not Available |
| Full Name | Summer Knight |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 1411 E 31st St, Oakland, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467636159 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 2004 (California) | Primary |
| 163WC0400X | Registered Nurse - Case Management | 567774 (California) | Secondary |
| Entity Name | Alameda Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740332931 PECOS PAC ID: 3779494521 Enrollment ID: O20031110000764 |
News Archive
Designing new therapeutic DNA aptamers with diverse side chains can improve their ability to interact with targets, and a new study describes characteristics of these side chains that may determine how long the aptamers remain in the bloodstream.
The number of serious adverse drug events reported to the U.S. Food and Drug Administration (FDA) more than doubled between 1998 and 2005, as did deaths associated with adverse drug events, according to a report in the September 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Cognizant today announced that it is working with HTH Worldwide, a global technology-based health services and information company, to enable its members to maximize the use of mobile technology for managing healthcare needs more effectively while traveling abroad. As part of the engagement, Cognizant is helping HTH Worldwide transform its mobile footprint through an enterprise mobile platform to support the company's rapidly growing business and further strengthen its leadership position in mobile medical assistance services.
ExonHit Therapeutics today announced the signing of an exclusive agreement with Genmab A/S for a selection of novel splice variants, identified as part of a successful pilot study, that have the potential to be therapeutic targets for breast cancer. Genmab retains exclusive development and commercialization rights on 10 events out of a breast cancer database developed using ExonHit's genome-wide SpliceArray technology (RNA splicing analysis platform covering the entire genome).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Summer Knight, RN, CNM 1411 E 31st St, Oakland, CA 94602-1018 Ph: (510) 435-8845 | Summer Knight, RN, CNM 1411 E 31st St, Oakland, CA 94602-1018 Ph: (510) 435-8845 |
News Archive
Designing new therapeutic DNA aptamers with diverse side chains can improve their ability to interact with targets, and a new study describes characteristics of these side chains that may determine how long the aptamers remain in the bloodstream.
The number of serious adverse drug events reported to the U.S. Food and Drug Administration (FDA) more than doubled between 1998 and 2005, as did deaths associated with adverse drug events, according to a report in the September 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Cognizant today announced that it is working with HTH Worldwide, a global technology-based health services and information company, to enable its members to maximize the use of mobile technology for managing healthcare needs more effectively while traveling abroad. As part of the engagement, Cognizant is helping HTH Worldwide transform its mobile footprint through an enterprise mobile platform to support the company's rapidly growing business and further strengthen its leadership position in mobile medical assistance services.
ExonHit Therapeutics today announced the signing of an exclusive agreement with Genmab A/S for a selection of novel splice variants, identified as part of a successful pilot study, that have the potential to be therapeutic targets for breast cancer. Genmab retains exclusive development and commercialization rights on 10 events out of a breast cancer database developed using ExonHit's genome-wide SpliceArray technology (RNA splicing analysis platform covering the entire genome).
› Verified 1 days ago
Sara Emily Neff Minahan, CNM, WHNP, RN Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1411 E 31st St, Oakland, CA 94602 Phone: 510-437-4800 | |
Ms. Jennifer Jonae Braddock, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1411 E 31st St, Oakland, CA 94602 Phone: 510-437-4570 | |
Briana Wilborn, CNM, NP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1411 E 31st St, Oakland, CA 94602 Phone: 510-437-4800 | |
Shan-yu Hoekman, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 350 30th St, Oakland, CA 94609 Phone: 510-869-8425 Fax: 510-506-7710 | |
Ms. Gina Maria Catena, CNM, NP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 350 30th St Ste 205, East Bay Perinatal Medical Association, Oakland, CA 94609 Phone: 510-444-0790 Fax: 510-869-8433 | |
Ms. Anna Lederman, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 365 Hawthorne Ave Ste 301, Oakland, CA 94609 Phone: 510-433-8793 | |
Mary Beth Canavan, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1030 International Blvd, Oakland, CA 94606 Phone: 510-238-5400 Fax: 510-238-5437 |